CA Patent

CA2326502C — Effervescent formulations

Assigned to Individual · Expires 2008-08-05 · 18y expired

What this patent protects

The invention relates to rapidly decomposing forms of administering alkali- sensitive active agents, more particularly selegiline, for oral applications in the form of fizzy formulations, containing an alkali-sensitive active age nt and a fizzy base consisting of one or several a…

USPTO Abstract

The invention relates to rapidly decomposing forms of administering alkali- sensitive active agents, more particularly selegiline, for oral applications in the form of fizzy formulations, containing an alkali-sensitive active age nt and a fizzy base consisting of one or several alkaline earth carbonates, an organically edible acid and/or alkali salt of a citric acid and optionally pharmaceutically usable additives.

Drugs covered by this patent

Patent Metadata

Patent number
CA2326502C
Jurisdiction
CA
Classification
Expires
2008-08-05
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.